LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 91

Search options

  1. Book ; Thesis: Auswirkungen von oxidativem Stress auf isolierte Pankreas-Azinuszellen und daraus abgeleitete experimentelle Ansätze für die Therapie der akuten Pankreatitis

    Schulz, Hans-Ulrich

    1998  

    Author's details vorgelegt von Hans-Ulrich Schulz
    Language German
    Size 126 Bl. : graph. Darst.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Magdeburg, Univ., Habil.-Schr., 1999
    HBZ-ID HT010831306
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Book ; Thesis: Azinuszellen aus Rattenpankreas

    Schulz, Hans-Ulrich

    Isolierung, Charakterisierung und Möglichkeiten ihres Einsatzes in Untersuchungen zur Pathogenese der akuten Pankreatitis

    1989  

    Author's details vorgelegt von Hans-Ulrich Schulz
    Keywords Pancreatitis / immunology ; Acute Disease ; Disease Models, Animal ; Rats ; Cell Separation / methods ; Pancreas / cytology ; Pancreas / immunology ; Dose-Response Relationship, Immunologic ; Dinitrophenols
    Size 64 Bl. : Ill., graph. Darst.
    Publishing country XA-DDDE
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Magdeburg, Med. Akad., Diss. A, 1989
    HBZ-ID HT003925907
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Article ; Online: Genetic Analysis of the ATG16L1 c.898A>G (p.T300A) Variant in Acute and Chronic Pancreatitis.

    Neubauer, Claudia / Ewers, Maren / Schulz, Hans-Ulrich / Weiß, Frank Ulrich / Lämmerhirt, Felix / Lerch, Markus M / Bugert, Peter / Landt, Olfert / Algül, Hana / Rosendahl, Jonas / Witt, Heiko

    Pancreas

    2023  Volume 51, Issue 9, Page(s) 1231–1234

    Abstract: Objectives: Human and animal studies suggest an important role of autophagy in the pathogenesis of pancreatitis. ATG16L1 (autophagy-related 16 like 1) is part of a protein complex that is involved in the formation of autophagosomes. The c.898A > G (p ... ...

    Abstract Objectives: Human and animal studies suggest an important role of autophagy in the pathogenesis of pancreatitis. ATG16L1 (autophagy-related 16 like 1) is part of a protein complex that is involved in the formation of autophagosomes. The c.898A > G (p.T300A) variant of ATG16L1 is associated with Crohn disease. In this study, we analyzed ATG16L1 c.898A > G (p.T300A) for an association with pancreatitis.
    Methods: We genotyped 777 patients and 551 control subjects of German origin by melting curve analysis using fluorescence resonance energy transfer probes. The patient group included 429 patients with nonalcoholic chronic pancreatitis (CP), 141 patients with alcoholic CP, and 207 patients with acute pancreatitis (AP). We classified AP by severity according to the Atlanta symposium 1992.
    Results: Allele and genotype frequencies of ATG16L1 c.898A > G (p.T300A) did not differ significantly between patients and controls (G allele frequencies: nonalcoholic CP, 49.9%; alcoholic CP, 48.2%; AP, 49.5%; controls, 52.7%). We found no significant association with the severity of AP either.
    Conclusions: Our data do not support a role of ATG16L1 c.898A > G (p.T300A) in the pathogenesis of AP or CP or an influence on the severity of AP.
    MeSH term(s) Animals ; Humans ; Acute Disease ; Autophagy-Related Proteins/genetics ; Pancreatitis/genetics ; Crohn Disease ; Gene Frequency ; Genetic Predisposition to Disease ; Autophagy/genetics ; Polymorphism, Single Nucleotide
    Chemical Substances Autophagy-Related Proteins ; ATG16L1 protein, human
    Language English
    Publishing date 2023-04-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632831-3
    ISSN 1536-4828 ; 0885-3177
    ISSN (online) 1536-4828
    ISSN 0885-3177
    DOI 10.1097/MPA.0000000000002177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Online ; Thesis: Untersuchungen zum Einfluss des Body-Mass-Index auf den Verlauf biochemischer Marker bei der akuten Pankreatitis

    Baatarkhuu, Munkhgerel / Schulz, Hans-Ulrich

    2014  

    Author's details von Munkhgerel Baatarkhuu
    Language German
    Size Online-Ressource (PDF-Datei), graph. Darst.
    Edition [Online-Ausg.]
    Publisher Medizinische Zentralbibl
    Publishing place Magdeburg
    Document type Book ; Online ; Thesis
    Thesis / German Habilitation thesis Univ., Med. Fak., Diss.--Magdeburg, 2014
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  5. Book ; Online ; Thesis: Untersuchungen zum Einfluss des Body-Mass-Index auf den Verlauf biochemischer Marker bei der akuten Pankreatitis

    Baatarkhuu, Munkhgerel [Verfasser] / Schulz, Hans-Ulrich [Akademischer Betreuer]

    2014  

    Author's details Munkhgerel Baatarkhuu. Betreuer: Hans-Ulrich Schulz
    Keywords Medizin, Gesundheit ; Medicine, Health
    Subject code sg610
    Language German
    Publisher Universitätsbibliothek
    Publishing place Magdeburg
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  6. Article ; Online: Mittelfristiges, relativ tumorstabiles Outcome eines erfolgreich interdisziplinär lokal R0-resezierten, metastasierten Leiomyosarkoms der V. cava inferior mit multimodaler Behandlung.

    Meyer, Frank / Weber, Mathias / Schulz, Hans-Ulrich / Halloul, Zuhir

    Wiener medizinische Wochenschrift (1946)

    2013  Volume 163, Issue 11-12, Page(s) 295–302

    Abstract: Unlabelled: Progredient tumor-growth does not mean necessarily nihilism since (because of the latest multimodal therapeutic options) it might be possible to convert the malignant disease into a chronic stage depending on tumor entity, specific tumor- ... ...

    Title translation Mid-term, relatively tumor-stable outcome after an initially successful interdisciplinary surgical intervention with locally achieved R0 resection status including a multimodal therapeutic concept of a metastasized leiomyosarcoma of the inferior vena cava.
    Abstract Unlabelled: Progredient tumor-growth does not mean necessarily nihilism since (because of the latest multimodal therapeutic options) it might be possible to convert the malignant disease into a chronic stage depending on tumor entity, specific tumor-associated findings and expertise of the interdisciplinary oncological/oncosurgical team to utilize available and potential therapeutic measures. The aim of this report on an unusual case (with its patient-associated, therapeutic and prognostic aspects) of a leiomyosarcoma of the inferior vena cava with advanced tumor growth (characterized initially by pulmonary and hepatic, later on by additional vertebral metastases) is to illustrate its changeful clinical course after and during multimodal treatment episodes comprising surgical (abdomino-/vascular-/cardio- and neurosurgical-locally, R0 resection status), radiological and chemotherapeutic measures. A relatively stable disease over a specific time period of 5 years and 6 months was achieved. The 54-year old female patient with metastasized leiomyosarcoma of the inferior vena cava underwent local tumor resection en bloc with inferior vena cava segmental resection (following vascular surgical interposition of a prosthesis) and hemihepatectomy as well as resection of hepatic segment I. After recovery, a multistep and -modal treatment was initiated comprising of various protocols of systemic chemotherapy, thermoablation of recurrent hepatic metastases, various brachytherapy procedures (for hepatic and pulmonary metastases) and resection of a cerebral metastasis by a neurosurgeon including subsequent radiation.
    Conclusions: The patient demonstrates impressively that even in case of advanced tumor stage with initial, novel and recurrent metastases, a relatively stable disease over an intermediate time period (of more than 5 years) with an acceptable quality of life was achieved despite several complications.
    MeSH term(s) Blood Vessel Prosthesis Implantation ; Chemoradiotherapy, Adjuvant ; Combined Modality Therapy ; Cooperative Behavior ; Disease Progression ; Female ; Follow-Up Studies ; Germany ; Humans ; Interdisciplinary Communication ; Leiomyosarcoma/diagnosis ; Leiomyosarcoma/pathology ; Leiomyosarcoma/therapy ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Staging ; Phlebography ; Postoperative Complications/diagnosis ; Postoperative Complications/etiology ; Prognosis ; Quality of Life ; Tomography, X-Ray Computed ; Treatment Outcome ; Vascular Neoplasms/diagnosis ; Vascular Neoplasms/pathology ; Vascular Neoplasms/therapy ; Vena Cava, Inferior/pathology
    Language German
    Publishing date 2013-01-19
    Publishing country Austria
    Document type Case Reports ; English Abstract ; Journal Article
    ZDB-ID 123613-1
    ISSN 1563-258X ; 0254-7945 ; 0043-5341
    ISSN (online) 1563-258X
    ISSN 0254-7945 ; 0043-5341
    DOI 10.1007/s10354-012-0172-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Serological diagnosis and prognosis of severe acute pancreatitis by analysis of serum glycoprotein 2.

    Roggenbuck, Dirk / Goihl, Alexander / Hanack, Katja / Holzlöhner, Pamela / Hentschel, Christian / Veiczi, Miklos / Schierack, Peter / Reinhold, Dirk / Schulz, Hans-Ulrich

    Clinical chemistry and laboratory medicine

    2017  Volume 55, Issue 6, Page(s) 854–864

    Abstract: Background: Glycoprotein 2 (GP2), the pancreatic major zymogen granule membrane glycoprotein, was reported to be elevated in acute pancreatitis in animal models.: Methods: Enzyme-linked immunosorbent assays (ELISAs) were developed to evaluate human ... ...

    Abstract Background: Glycoprotein 2 (GP2), the pancreatic major zymogen granule membrane glycoprotein, was reported to be elevated in acute pancreatitis in animal models.
    Methods: Enzyme-linked immunosorbent assays (ELISAs) were developed to evaluate human glycoprotein 2 isoform alpha (GP2a) and total GP2 (GP2t) as specific markers for acute pancreatitis in sera of 153 patients with acute pancreatitis, 26 with chronic pancreatitis, 125 with pancreatic neoplasms, 324 with non-pancreatic neoplasms, 109 patients with liver/biliary disease, 67 with gastrointestinal disease, and 101 healthy subjects. GP2a and GP2t levels were correlated with procalcitonin and C-reactive protein in 152 and 146 follow-up samples of acute pancreatitis patients, respectively.
    Results: The GP2a ELISA revealed a significantly higher assay accuracy in contrast to the GP2t assay (sensitivity ≤3 disease days: 91.7%, specificity: 96.7%, positive likelihood ratio [LR+]: 24.6, LR-: 0.09). GP2a and GP2t levels as well as prevalences were significantly elevated in early acute pancreatitis (≤3 disease days) compared to all control cohorts (p<0.05, respectively). GP2a and GP2t levels were significantly higher in patients with severe acute pancreatitis at admission compared with mild cases (p<0.05, respectively). Odds ratio for GP2a regarding mild vs. severe acute pancreatitis with lethal outcome was 7.8 on admission (p=0.0222). GP2a and GP2t levels were significantly correlated with procalcitonin [Spearman's rank coefficient of correlation (ρ)=0.21, 0.26; p=0.0110, 0.0012; respectively] and C-reactive protein (ρ=0.37, 0.40; p<0.0001; respectively).
    Conclusions: Serum GP2a is a specific marker of acute pancreatitis and analysis of GP2a can aid in the differential diagnosis of acute upper abdominal pain and prognosis of severe acute pancreatitis.
    MeSH term(s) Acute Disease ; Adult ; Aged ; Blood Chemical Analysis ; Case-Control Studies ; Cohort Studies ; Female ; GPI-Linked Proteins/blood ; Humans ; Male ; Middle Aged ; Pancreatitis/blood ; Pancreatitis/diagnosis ; Prognosis ; Protein Isoforms/blood ; Serologic Tests
    Chemical Substances GP2 protein, human ; GPI-Linked Proteins ; Protein Isoforms
    Language English
    Publishing date 2017-05-01
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1418007-8
    ISSN 1437-4331 ; 1434-6621 ; 1437-8523
    ISSN (online) 1437-4331
    ISSN 1434-6621 ; 1437-8523
    DOI 10.1515/cclm-2016-0797
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects.

    Abebe, Bayew Tsega / Weiss, Michael / Modess, Christiane / Roustom, Tarek / Tadken, Tobias / Wegner, Danilo / Schwantes, Ulrich / Neumeister, Claudia / Schulz, Hans-Ulrich / Scheuch, Eberhard / Siegmund, Werner

    Journal of clinical pharmacology

    2019  Volume 59, Issue 10, Page(s) 1319–1330

    Abstract: The quaternary ammonium compound trospium chloride is poorly absorbed from 2 "absorption windows" in the jejunum and cecum/ascending colon, respectively. To confirm whether intestinal P-glycoprotein (P-gp) is involved, a 4-period, crossover drug ... ...

    Abstract The quaternary ammonium compound trospium chloride is poorly absorbed from 2 "absorption windows" in the jejunum and cecum/ascending colon, respectively. To confirm whether intestinal P-glycoprotein (P-gp) is involved, a 4-period, crossover drug interaction study with trospium chloride after intravenous (2 mg) and oral administration (30 mg) without and after comedication of clarithromycin (500 mg), an inhibitor for P-gp, was initiated in 12 healthy subjects. Pharmacokinetics of trospium was evaluated using gas chromatography-mass spectrometry, noncompartmental evaluation, and pharmacokinetic modeling. Trospium chloride was poorly absorbed after oral administration (absolute bioavailability, ∼8%-10%). About 30% of the bioavailable dose fraction was absorbed from the "narrow window". Comedication with clarithromycin increased steady-state distribution volumes by ∼27% (P < .01). Bioavailability was not increased as hypothesized. The geometric mean ratios (90% confidence interval) for area under the plasma concentration-time curve, maximum concentration, and renal clearance accounted for 0.75 (0.56-1.01), 0.64 (0.45-0.89), and 1.00 (0.90-1.13), respectively. The amount of trospium absorbed from the "narrow window" was reduced in all subjects but from the "wider window" in only 9 of them. Bioavailability was strongly predicted by the maximum absorption rate of trospium in the distal "window" (rs
    MeSH term(s) ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors ; Administration, Intravenous/methods ; Administration, Oral ; Adult ; Area Under Curve ; Benzilates/pharmacokinetics ; Biological Availability ; Clarithromycin/pharmacology ; Cross-Over Studies ; Drug Interactions/physiology ; Female ; Healthy Volunteers ; Humans ; Male ; Muscarinic Antagonists/pharmacokinetics ; Nortropanes/pharmacokinetics
    Chemical Substances ATP Binding Cassette Transporter, Subfamily B, Member 1 ; Benzilates ; Muscarinic Antagonists ; Nortropanes ; trospium chloride (1E6682427E) ; Clarithromycin (H1250JIK0A)
    Language English
    Publishing date 2019-04-11
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.1421
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pharmacokinetic Drug-Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects.

    Abebe, Bayew Tsega / Weiss, Michael / Modess, Christiane / Tadken, Tobias / Wegner, Danilo / Meyer, Marleen J / Schwantes, Ulrich / Neumeister, Claudia / Scheuch, Eberhard / Schulz, Hans-Ulrich / Tzvetkov, Mladen / Siegmund, Werner

    Journal of clinical pharmacology

    2019  Volume 60, Issue 3, Page(s) 312–323

    Abstract: Trospium chloride, a muscarinic receptor blocker, is poorly absorbed with different rates from areas in the jejunum and the cecum/ascending colon. To evaluate whether organic cation transporter (OCT) 1, OCT2 and multidrug and toxin extrusion (MATE) 1 and ...

    Abstract Trospium chloride, a muscarinic receptor blocker, is poorly absorbed with different rates from areas in the jejunum and the cecum/ascending colon. To evaluate whether organic cation transporter (OCT) 1, OCT2 and multidrug and toxin extrusion (MATE) 1 and MATE2-K are involved in pharmacokinetics, competitions with ranitidine, a probe inhibitor of the cation transporters, were evaluated in transfected HEK293 cells. Furthermore, a drug interaction study with trospium chloride after intravenous (2 mg) and oral dosing (30 mg) plus ranitidine (300 mg) was performed in 12 healthy subjects and evaluated by noncompartmental analysis and population pharmacokinetic modeling. Ranitidine inhibited OCT1, OCT2, MATE1, and MATE2-K with half maximal inhibitory concentration values of 186 ± 25 µM, 482 ± 105 µM, 134 ± 37 µM, and 35 ± 11 µM, respectively. In contrast to our hypothesis, coadministration of ranitidine did not significantly decrease oral absorption of trospium. Instead, renal clearance was lowered by ∼15% (530 ± 99 vs 460 ± 120 mL/min; P < .05). It is possible that ranitidine was not available in competitive concentrations at the major colonic absorption site, as the inhibitor is absorbed in the small intestine and undergoes degradation by microbiota. The renal effects apparently result from inhibition of MATE1 and/or MATE2-K by ranitidine as predicted by in vitro to in vivo extrapolation. However, all pharmacokinetic changes were not of clinical relevance for the drug with highly variable pharmacokinetics. Intravenous trospium significantly lowered mean absorption time and relative bioavailability of ranitidine, which was most likely caused by muscarinic receptor blocking effects on intestinal motility and water turnover.
    MeSH term(s) Administration, Intravenous ; Administration, Oral ; Adult ; Benzilates/administration & dosage ; Benzilates/adverse effects ; Benzilates/blood ; Benzilates/pharmacokinetics ; Biological Availability ; Cells, Cultured ; Drug Interactions ; Female ; Healthy Volunteers ; Humans ; Male ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/adverse effects ; Muscarinic Antagonists/blood ; Muscarinic Antagonists/pharmacokinetics ; Nortropanes/administration & dosage ; Nortropanes/adverse effects ; Nortropanes/blood ; Nortropanes/pharmacokinetics ; Organic Cation Transport Proteins/antagonists & inhibitors ; Organic Cation Transport Proteins/metabolism ; Ranitidine/administration & dosage ; Ranitidine/blood ; Ranitidine/pharmacokinetics ; Ranitidine/pharmacology
    Chemical Substances Benzilates ; Muscarinic Antagonists ; Nortropanes ; Organic Cation Transport Proteins ; trospium chloride (1E6682427E) ; Ranitidine (884KT10YB7)
    Language English
    Publishing date 2019-09-22
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.1523
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Conference proceedings: Spektrum, Häufigkeit und Versorgung intraoperativer, iatrogener Gefäßverletzung bei viszeralchirurgischen Eingriffen an einem tertiären Zentrum

    Scholtz, Veronika / Meyer, Frank / Meißner, Carl / Schulz, Hans-Ulrich / Halloul, Zuhir

    2016  , Page(s) 16dgch546

    Event/congress 133. Kongress der Deutschen Gesellschaft für Chirurgie; Berlin; Deutsche Gesellschaft für Chirurgie; 2016
    Keywords Medizin, Gesundheit
    Publishing date 2016-04-21
    Publisher German Medical Science GMS Publishing House; Düsseldorf
    Document type Conference proceedings
    DOI 10.3205/16dgch546
    Database German Medical Science

    More links

    Kategorien

To top